Home › Neuroblastoma › New Jersey › Edison
Neuroblastoma clinical trials in Edison, NJ
4 studies for Neuroblastoma are looking for participants at sites in and around Edison (within about 30 miles). Open a study to see who can join and how to contact the study team.
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Saint Peter's University Hospital, New Brunswick · 3 mi away
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi away
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
RecruitingPhase 1/2
- Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick · 3 mi away
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Saint Peter's University Hospital, New Brunswick · 3 mi away
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi away
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
RecruitingPhase 2
- Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge · 15 mi away
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Dallas, TX9 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- St. Louis, MO9 studies
- Aurora, CO8 studies
- Hartford, CT8 studies
- Birmingham, AL8 studies
- Minneapolis, MN8 studies
- San Francisco, CA7 studies
Other studies in Edison
- Breast Cancer69 studies
- Non-Small Cell Lung Cancer47 studies
- Cancer (all types)33 studies
- Prostate Cancer30 studies
- Lung Cancer24 studies
- Colorectal Cancer24 studies
- Bladder Cancer22 studies
- Multiple Myeloma22 studies
- Acute Myeloid Leukemia21 studies
- Endometrial Cancer20 studies
- Ovarian Cancer20 studies
- Metastatic Cancer18 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.